Neurodevelopmental disorders are a group of conditions characterized by impairments in the growth and development of the brain or central nervous system
Chromosomal Abnormalities: Conditions like Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13) result from an abnormal number of chromosomes
Single Gene Mutations: Disorders such as Fragile X syndrome, Rett syndrome, and Duchenne muscular dystrophy are caused by mutations in a single gene
Collaborative research efforts involving multiple institutions and researchers worldwide have led to significant advancements in understanding and treating developmental disorders
Pooling large datasets and sharing research findings globally accelerates progress in identifying genetic causes, developing therapies, and improving outcomes for affected individuals
Intellectual disability refers to significant limitations in intellectual functioning (IQ below 70) and adaptive behavior, which typically manifest before the age of 18
ADHD is characterized by inattention, hyperactivity, and impulsivity, which can impact academic performance, social interactions, and daily functioning
Early intervention programs provide specialized support and therapies to infants and toddlers with developmental delays or disabilities to enhance their development and learning
Genetic counselors assess familial risks, explain genetic test results, and provide guidance on inheritance patterns, recurrence risks, and available reproductive options
Pharmacogenomics is the study of how genetic variations influence an individual's response to medications, including dosage requirements, efficacy, and potential side effects
Understanding pharmacogenomics helps tailor medication regimens for individuals with developmental disorders based on their genetic profiles for optimal treatment outcomes
ABA is a structured therapy that uses positive reinforcement to teach and reinforce desired behaviors while reducing challenging behaviors in individuals with developmental disorders